Is Now An Opportune Moment To Examine Aehr Test Systems (NASDAQ:AEHR)?

In this article:

Aehr Test Systems (NASDAQ:AEHR), might not be a large cap stock, but it saw significant share price movement during recent months on the NASDAQCM, rising to highs of US$18.78 and falling to the lows of US$10.36. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether Aehr Test Systems' current trading price of US$11.14 reflective of the actual value of the small-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let’s take a look at Aehr Test Systems’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change.

See our latest analysis for Aehr Test Systems

Is Aehr Test Systems Still Cheap?

The stock is currently trading at US$11.14 on the share market, which means it is overvalued by 25% compared to our intrinsic value of $8.92. This means that the buying opportunity has probably disappeared for now. If you like the stock, you may want to keep an eye out for a potential price decline in the future. Since Aehr Test Systems’s share price is quite volatile, this could mean it can sink lower (or rise even further) in the future, giving us another chance to invest. This is based on its high beta, which is a good indicator for how much the stock moves relative to the rest of the market.

What kind of growth will Aehr Test Systems generate?

earnings-and-revenue-growth
earnings-and-revenue-growth

Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. However, with an extremely negative double-digit change in profit expected next year, near-term growth is certainly not a driver of a buy decision. It seems like high uncertainty is on the cards for Aehr Test Systems, at least in the near future.

What This Means For You

Are you a shareholder? If you believe AEHR should trade below its current price, selling high and buying it back up again when its price falls towards its real value can be profitable. Given the risk from a negative growth outlook, this could be the right time to de-risk your portfolio. But before you make this decision, take a look at whether its fundamentals have changed.

Are you a potential investor? If you’ve been keeping an eye on AEHR for a while, now may not be the best time to enter into the stock. Its price has risen beyond its true value, on top of a negative future outlook. However, there are also other important factors which we haven’t considered today, such as the financial strength of the company. Should the price fall in the future, will you be well-informed enough to buy?

If you want to dive deeper into Aehr Test Systems, you'd also look into what risks it is currently facing. For example, Aehr Test Systems has 3 warning signs (and 2 which are concerning) we think you should know about.

If you are no longer interested in Aehr Test Systems, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Advertisement